© Reuters.
Sunrest Lifescience Limited commenced its journey on the NSE SME platform today with its shares opening at the initial public offering (IPO) price of ₹84. Despite a favorable grey market premium (GMP) indicating a higher expected valuation, the stock experienced a decline shortly after trading began, falling by more than 4% to ₹80.5.
The company’s IPO, which ran from…